Educational session

Q&A

Date
Thu, 23.02.2023
Time
16:30 - 17:50
Room
Auditorium 113
Duration
15 Minutes
Educational session

Introduction

Speakers
  • Bradley J. Monk (Tucson, United States of America)
Date
Thu, 23.02.2023
Time
16:30 - 17:50
Room
Auditorium 113
Duration
5 Minutes
Educational session

Understanding the basics: Structure, key properties, mechanism of action, optimal diagnostic test to determine the target

Speakers
  • Kathleen N. Moore (Oklahoma City, Oklahoma, United States of America)
Date
Thu, 23.02.2023
Time
16:30 - 17:50
Room
Auditorium 113
Duration
15 Minutes
Educational session

The evolving ADC treatment landscape in ovarian cancer

Speakers
  • Nicole Concin (Innsbruck, Austria)
Date
Thu, 23.02.2023
Time
16:30 - 17:50
Room
Auditorium 113
Duration
15 Minutes
Educational session

Role of ADCs in cervical cancer treatment in the era of immunotherapy

Speakers
  • Bradley J. Monk (Tucson, United States of America)
Date
Thu, 23.02.2023
Time
16:30 - 17:50
Room
Auditorium 113
Duration
15 Minutes
Educational session

The new challenge: ADC class effects, on/off-target adverse reactions and their interdisciplinary management

Speakers
  • Toon Van Gorp (Leuven, Belgium)
Date
Thu, 23.02.2023
Time
16:30 - 17:50
Room
Auditorium 113
Duration
15 Minutes
Educational session

Introduction

Speakers
  • Domenica Lorusso (Rome, Italy)
Date
Fri, 24.02.2023
Time
10:15 - 11:35
Room
Auditorium 113
Duration
5 Minutes
Educational session

Revisiting the adjuvant therapy in endometrial cancer: ESMO Guidelines

Speakers
  • Carien L. Creutzberg (Leiden, Netherlands)
Date
Fri, 24.02.2023
Time
10:15 - 11:35
Room
Auditorium 113
Duration
15 Minutes
Educational session

Is immunotherapy changing the face of recurrent/metastatic endometrial cancer?

Speakers
  • Ana Oaknin (Barcelona, Spain)
Date
Fri, 24.02.2023
Time
10:15 - 11:35
Room
Auditorium 113
Duration
15 Minutes
Educational session

Are all dMMR/MSI-H endometrial cancer the same disease?

Speakers
  • Xavier Matias-Guiu (Hospitalet de Llobregat, Spain)
Date
Fri, 24.02.2023
Time
10:15 - 11:35
Room
Auditorium 113
Duration
15 Minutes
Educational session

Beyond immunotherapy: What is the role of HER2, p53 and other molecular targets in the recurrent/metastatic endometrial cancer treatment landscape?

Speakers
  • Mansoor Raza Mirza (Copenhagen, Denmark)
Date
Fri, 24.02.2023
Time
10:15 - 11:35
Room
Auditorium 113
Duration
15 Minutes
Educational session

Q&A

Date
Fri, 24.02.2023
Time
10:15 - 11:35
Room
Auditorium 113
Duration
15 Minutes